-VISIT OUR OTHER FORUMS- OB-GYN-L Ultrasound Ultrasound History Fibroid Forum Physicians-in-Training Tech Talk OBSTET-L (portuguese) OBGIN-L (spanish) Nursing

Is anyone concerned about health and liability risk involving infused ibandronate... From: Annette Keen (akeen@Capital.net) Sat May 30 01:50:31 2009 Messages sorted by: [ date ][ thread ][ subject ][ author ] Next message: art fougner, md: "Re: Is anyone concerned about health and liability risk involving infused ibandronate..." Previous message: DoctorJoe@aol.com: "Re: FRI: Another frivolous lawsuit!" Next in thread: art fougner, md: "Re: Is anyone concerned about health and liability risk involving infused ibandronate..." Reply: art fougner, md: "Re: Is anyone concerned about health and liability risk involving infused ibandronate..." which is being heavily advertised and marketed. There are reports that Merck's research on bisphosphanates in general may have lacked peer review the company implied. -- A. Keen Next message: art fougner, md: "Re: Is anyone concerned about health and liability risk involving infused ibandronate..." Previous message: DoctorJoe@aol.com: "Re: FRI: Another frivolous lawsuit!" Next in thread: art fougner, md: "Re: Is anyone concerned about health and liability risk involving infused ibandronate..." Reply: art fougner, md: "Re: Is anyone concerned about health and liability risk involving infused ibandronate..."

Return to

Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Wed Dec 2 05:13:53 2009

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.